Product
Ganaplacide
Aliases
KAF156
3 clinical trials
1 indication
Indication
MalariaClinical trial
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Investigate the Effect of Efavirenz on the Pharmacokinetics of Ganaplacide and Lumefantrine Combination in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-11-22
Clinical trial
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of Ganaplacide and Lumefantrine Combination on the Pharmacokinetics of Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-10-17